sacubitril,valsartan
novartis,rovi pharmaceuticals laboratories
['valsartan', 'paragon', 'sacubitril', 'sacubitril,valsartan', 'cardio']
in this paper, authors evaluate the association between the occurrence of moderate egfr decline(&gt;15%) after initial exposure to sacubitril/valsartan &amp; subsequent cardiovascular outcomes &amp; its treatment benefits in paradigm-hf &amp; paragon-hf #acc23/#wccardio
We publish the world's finest selection of cardiology journals, reference books, periodicals, and online resources. Publishing support: https://t.co/hgIOpLZL7v